Brilacidin, a novel antifungal agent against Cryptococcus neoformans

By sjmartinez • June 26, 2024

Diehl C, Pinzan CF, de Castro PA, Delbaje E, García Carnero LC, Sánchez-León E, Bhalla K, Kronstad JW, Kim D-g, Doering TL, Alkhazraji S, Mishra NN, Ibrahim AS, Yoshimura M, Vega Isuhuaylas LA, Pham LTK, Yashiroda Y, Boone C, Dos Reis TF, Goldman GH. Brilacidin, a novel antifungal agent against Cryptococcus neoformans. mBio. 2024 Jun 25:e0103124. doi: 10.1128/mbio.01031-24. Epub ahead of print. PMID: 38916308.

Tags: antifungal agent, brilacidin, caspofungin, Cryptococcus neoformans, Harbor UCLA, Infectious Diseases, Publications

Related Posts

Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease

Rhee CM, Narasaki Y, Crowley ST, Kovesdy CP, Mukamel DB, You AS, Nguyen M, Siu MKM, Le L, Novoa A, Nguyen DV, Kalantar-Zadeh K. Nondialytic[...]

Prediction of the Statin responders with radiomics

Lee SE, Hong Y, Jung J, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb[...]

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes

Narasaki Y, Kalantar-Zadeh K, Zisman-Ilani Y, Klonoff DC, Kovesdy CP, Li Z, Jin A, Crowley S, M Belcher J, Gee P, Gin GE, Jordan M,[...]